<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00241</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;b&hyph;(9). Liquid effluent from containment equipment, sinks,  <!-- PJG 0012 frnewline --> biological safety cabinets, animal rooms, primary barriers, floor drains, and  <!-- PJG 0012 frnewline --> sterilizers shall be decontaminated by heat treatment before being released into  <!-- PJG 0012 frnewline --> the sanitary system. Liquid wastes from shower rooms and toilets shall be  <!-- PJG 0012 frnewline --> decontaminated with chemical disinfectants or heat by methods demonstrated to be  <!-- PJG 0012 frnewline --> effective. The procedure used for heat decontamination of liquid wastes shall be  <!-- PJG 0012 frnewline --> monitored with a recording thermometer. The effectiveness of the heat  <!-- PJG 0012 frnewline --> decontamination process system shall be revalidated every 30 days with an  <!-- PJG 0012 frnewline --> indicator organism. Liquid wastes from the shower shall be chemically  <!-- PJG 0012 frnewline --> decontaminated using an Environmental Protection Agency-approved germicide.  <!-- PJG 0012 frnewline --> The efficacy of the chemical treatment process shall be validated with an indicator  <!-- PJG 0012 frnewline --> organism. Chemical disinfectants shall be neutralized or diluted before release  <!-- PJG 0012 frnewline --> into general effluent waste systems.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;c. Signs (BL4&hyph;N)  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;c&hyph;(1). When the animal research requires special provisions for  <!-- PJG 0012 frnewline --> entry (e.g., vaccination), a warning sign incorporating the universal biosafety  <!-- PJG 0012 frnewline --> symbol shall be posted on all access doors to the animal work area. The sign shall  <!-- PJG 0012 frnewline --> indicate: (i) the agent, (ii) the animal species, (iii) the name and telephone  <!-- PJG 0012 frnewline --> number of the Animal Facility Director, or other responsible individual, and (iv)  <!-- PJG 0012 frnewline --> any special requirements for entering the laboratory.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;d. Protective Clothing (BL4&hyph;N)  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;d&hyph;(1). Individuals shall enter and exit the animal facility only  <!-- PJG 0012 frnewline --> through the clothing change and shower rooms. Street clothing shall be removed  <!-- PJG 0012 frnewline --> and kept in the outer clothing change room. Complete laboratory clothing (may be  <!-- PJG 0012 frnewline --> disposable), including undergarments, pants, shirts, jump suits, and shoes shall be  <!-- PJG 0012 frnewline --> provided for all personnel entering the animal facility. When exiting the BL4&hyph;N  <!-- PJG 0012 frnewline --> area and before proceeding into the shower area, personnel shall remove their  <!-- PJG 0012 frnewline --> laboratory clothing in the inner change room. All laboratory clothing shall be  <!-- PJG 0012 frnewline --> autoclaved before laundering. Personnel shall shower each time they exit the  <!-- PJG 0012 frnewline --> animal facility.  <!-- PJG 0012 frnewline --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;d&hyph;(2). A ventilated head-hood or a one-piece positive pressure  <!-- PJG 0012 frnewline --> suit, which is ventilated by a life-support system, shall be worn by all personnel  <!-- PJG 0012 frnewline --> entering rooms that contain experimental animals when appropriate. When  <!-- PJG 0012 frnewline --> ventilated suits are required, the animal personnel shower entrance/exit area shall  <!-- PJG 0012 frnewline --> be equipped with a chemical disinfectant shower to decontaminate the surface of  <!-- PJG 0012 frnewline --> the suit before exiting the area. A neutralization or water dilution device shall be  <!-- PJG 0012 frnewline --> integral with the chemical disinfectant discharge piping before entering the heat  <!-- PJG 0012 frnewline --> sterilization system. Entry to this area shall be through an airlock fitted with  <!-- PJG 0012 frnewline --> airtight doors.  <!-- PJG 0012 frnewline --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;d&hyph;(3). Appropriate respiratory protection shall be worn in  <!-- PJG 0012 frnewline --> rooms containing experimental animals.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;e. Records (BL4&hyph;N)  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;e&hyph;(1). Documents regarding experimental animal use and  <!-- PJG 0012 frnewline --> disposal shall be maintained in a permanent record book.  <!-- PJG 0012 frnewline --> Appendix Q&hyph;II&hyph;D&hyph;1&hyph;e&hyph;(2). A system shall be established for: (i) Reporting  <!-- PJG 0012 frnewline --> laboratory accidents and exposures that are a result of overt exposures to  <!-- PJG 0012 frnewline --> organisms containing recombinant DNA, (ii) employee absenteeism, and (iii)  <!-- PJG 0012 frnewline --> medical surveillance of potential laboratory-associated illnesses. Permanent  <!-- PJG 0012 frnewline --> records shall be prepared and maintained. Any incident involving spills and  <!-- PJG 0012 frnewline --> accidents that results in environmental release or exposures of animals or  <!-- PJG 0012 frnewline --> laboratory workers to organisms containing recombinant DNA molecules shall be  <!-- PJG 0012 frnewline --> reported immediately to the Biological Safety Officer, Animal Facility Director,  <!-- PJG 0012 frnewline --> Institutional Biosafety Committee, NIH/ORDA, and other appropriate authorities  <!-- PJG 0012 frnewline --> (if applicable). Reports to the NIH/ORDA shall be sent to the Office of  <!-- PJG 0012 frnewline --> Recombinant DNA Activities, National Institutes of Health, Building 31, Room  <!-- PJG 0012 frnewline --> 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838. Medical evaluation, surveillance,  <!-- PJG 0012 frnewline --> and treatment shall be provided as appropriate and written records maintained. If  <!-- PJG 0012 frnewline --> necessary, the area shall be appropriately decontaminated.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            